[Pneumatosis intestinalis in a patient of myasthenia gravis treated with high-dose corticosteroid].
We report a patient who developed persistent and severe diarrhea in the course of high-dose corticosteroid therapy for myasthenia gravis (MG). The patient, a 37-year-old woman, developed diplopia, ptosis, and muscle weakness with fatigability. She was admitted to our hospital and was diagnosed as having MG. Five months after thymectomy and oral corticosteroid administration, she developed abdominal pain and severe diarrhea. Abdominal X-ray, showed extensive pericolic gas accumulation surrounding the ascending and transverse colon. She was diagnosed as having pneumatosis intestinalis (PI). Hyperbaric therapy was not effective. Symptoms began to improve gradually when the dose of prednisolone was reduced. PI is a rare condition characterized by gas-filled cysts or linear gas in the bowel wall caused by a variety of disorders and drugs such as necrotizing colitis, obstructive pulmonary diseases, and immunosuppressants. In the present case, PI appeared to be induced by corticosteroid therapy. To our knowledge, MG complicated by PI is unusual, but this rare case highlights the importance of taking it into consideration during steroid therapy for MG.
Kameyama
Kaori
K
Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University.
Noguchi
Yoshimasa
Y
Matsumoto
Takashi
T
Takenawa
Hiroshi
H
Fujigasaki
Hiroto
H
Kanda
Takashi
T
Mizusawa
Hidehiro
H
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003967:Diarrhea / Q000209:etiology*; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy*; D011006:Pneumatosis Cystoides Intestinalis / Q000209:etiology*; D011239:Prednisolone / Q000008:administration & dosage*
D000893:Anti-Inflammatory Agents; D011239:Prednisolone